 |
인쇄하기
취소
|
Boryung Pharm signs $15 million Kanarb export deal
Local drug maker Boryung Pharmaceutical said Monday it has signed a contract with R-Pharm of Russia to export newly developed Kanarb (fimasartan) for treatment of hypertension.
This agreement will allow Dong-A to export about 15 million dollars of Kanarb as well as a royalty of $1.5 million to Russia over a five year period.
Fimasartan is a non-peptide AT1 receptor antagonist, blocks the...
This agreement will allow Dong-A to export about 15 million dollars of Kanarb as well as a royalty of $1.5 million to Russia over a five year period.
Fimasartan is a non-peptide AT1 receptor antagonist, blocks the...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.